Pioneering Breakthroughs for Young Adults with Cancer
The Society of MSK’s 2024-2025 Campaign will fund leading-edge research at MSK that aims to understand why cases of colorectal and gastrointestinal cancers are rising worldwide for people under 50 and to find more effective and less toxic therapies to treat these diseases.
Driving scientific discovery and patient care
Colorectal and gastrointestinal cancer diagnoses are rising worldwide for people under 50. MSK is at the forefront of responding to this global health crisis. With your support, our experts can conduct leading-edge cancer research, discover more effective therapies, and provide individualized care plans and support services for patients.
Accelerating progress
Explore The Society of MSK 2024-2025 Campaign brochure.
Read now
What The Society of MSK funds
Since 1946, The Society of MSK has funded critical research projects, ensuring that patients have access to life-changing cancer care. This support has been essential to MSK’s ability to thrive without limits and help people worldwide. Read about areas of past support below.
New therapies for lymphoma
Home to one of the world’s largest and most innovative research and clinical trial programs focused on lymphoma, MSK is uniquely positioned to uncover new cancer therapies that improve outcomes for people with this disease.
Breakthroughs in immunotherapy
MSK is a global leader in immunotherapy, the revolutionary approach that uses the body’s own immune system to fight cancer. Our scientists are exploring new ways to enable more people with cancer to benefit from this novel treatment.
Pancreatic cancer care advances
Pancreatic cancer is often not detected until it has reached a late stage. Through innovative research, MSK scientists are transforming cancer care for people with pancreatic cancer around the world.
Join us in making this year’s Society Campaign a success.
